REGENERON Trademark

Trademark Overview

On Friday, May 23, 2025, a trademark application was filed for REGENERON with the United States Patent and Trademark Office. The USPTO has given the REGENERON trademark a serial number of 99199652. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, May 23, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents, and biological preparations, namely, viral vectors, all for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; pharmaceutical preparations for immunotherapy treatment, cell therapy, nucleic acid therapy, and gene therapy
regeneron

General Information

Serial Number99199652
Word MarkREGENERON
Filing DateFriday, May 23, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, May 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents, and biological preparations, namely, viral vectors, all for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; pharmaceutical preparations for immunotherapy treatment, cell therapy, nucleic acid therapy, and gene therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 23, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Friday, May 23, 2025NEW APPLICATION ENTERED
Friday, May 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 23, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

regeneron diseases namely treatment preparations therapy autoimmune cancer pharmaceutical infectious system